ライフサイエンスコーパス: be completed

1 nally be shown and the analytical data could be completed.

2 red with ClinicalTrials.gov, NCT02848326 and is completed.

3 red with ClinicalTrials.gov, NCT01895777 and is completed.

4 inicalTrials.gov, NCT02924376, and enrolment is completed.

5 defer DAA therapy until after HCC treatment is completed.

6 ISRCTN registry, number ISRCTN41083256, and is completed.

7 ered with ISRCTN, number ISRCTN22888906, and is completed.

8 ield stage and decreasing once morphogenesis is completed.

9 and all research related to Lung-MAP (S1400) is completed.

10 Trials Number registry (ISRCTN46754188) and is completed.

11 programme until the cell proliferation phase is completed.

12 ith the ISRCTN registry, ISRCTN68382401, and is completed.

13 registered with ISRCTN, ISRCTN92746680, and is completed.

14 ed with ClinicalTrials.gov, NCT01798680, and is completed.

15 ons not possible until future cohort studies are completed.

16 me 18 participants two years after treatment was completed.

17 ions were discontinued and cognitive testing was completed.

18 location policies, the first successful case was completed.

19 bsence of CH(3)I, but adding it once the CPE was completed.

20 hesive hyaluronan matrix after cell division was completed.

21 on until 6 months after antibiotic treatment was completed.

22 s were minimal after 1/4 of the fermentation was completed.

23 il the critical portion of the first surgery was completed.

24 cterization of the glycoproteome has not yet been completed.

25 inicalTrials.gov, number NCT02234843 and has been completed.

26 nes used during the 2017-2018 season has not been completed.

27 ClinicalTrials.gov, NCT02937454, and has now been completed.

28 t vaccines used during the 2017-2018 has not been completed.

29 artments like the intestinal mucosa, has not been completed.

30 nterest, relatively few total syntheses have been completed.

31 ls of iPSC-derived cells have not previously been completed.

32 atients with HER2-positive breast cancer has been completed.

33 the pericardium and circulatory system have been completed.

34 nd prospective clinical trials have recently been completed.

35 extracorporeal membrane oxygenation have not been completed.

36 The trial, including all follow-up, has been completed.

37 alTrials.gov, NCT02924883, and the study has been completed.

38 RVX-208 (now called apabetalone) has already been completed.

39 s), subtypes and HIV-1 diversity estimations were completed.

40 69 carotid MR imaging studies were completed.

41 ible PICU admissions, for whom 1,218 surveys were completed.

42 Histologic analyses of lesions were completed.

43 30 family member and 3,999 clinician surveys were completed.

44 93% of planned plasma infusions were completed.

45 A total of 700 patient surveys were completed.

46 ut the veterans health administration system were completed.

47 hundred forty-two perioperative enhancements were completed.

48 nvestigator until all other study procedures were completed.

49 ial feasibility purposes, 6-month follow-ups were completed.

50 21 August 2017) and before trial recruitment was completed (30 September 2018) when informed that pro

51 A total of 2295 of 5282 surveys were completed (43.4% response rate).

52 nodes of Ranvier and appears as myelination is completed, acting as an ion-diffusion barrier that af

53 lment, neoadjuvant therapy, and surgery have been completed; adjuvant treatment and follow-up are ong

54 cording to the ROC curve, the learning curve was completed after 25 procedures.

55 After randomization, antibiotic treatment was completed after a median of 19 days (interquartile r

56 ods This HIPAA-compliant retrospective study was completed after institutional review board approval.

57 for target immobilization and the selection was completed after ten rounds.

58 Of the total, 1,243 were completed after 2007, when the mean 1-year publicat

59 t-Traumatic Stress Scale 10 intensive part B were completed after inclusion, and reevaluated after 3,

60 consensus was reached or 4 survey rounds had been completed, after which the question was categorized

61 aphic/behavioral/psychosocial questionnaires were completed, along with HIV and HCV testing.

62 s the phase 1b 25-mg lenalidomide cohort was being completed; an additional 25-mg cohort in phase 2 i

63 A prototype 3-segment imager has been completed and tested with an active 64-cm axial fie

64 This trial has been completed and the final results are reported.

65 number of randomized controlled trials have been completed and the first drugs, all therapeutic mono

66 Recruitment has been completed and the trial is ongoing.

67 This trial has been completed and was registered with the ISRCTN, numbe

68 This study is completed and was registered with the ISRCTN, number

69 reveal that of 103 pit latrines studied, 88% were completed and in use, but only 35% were operated ap

70 st year, three cardiovascular outcome trials were completed and showed that PCSK9 inhibitors signific

71 cutoff, the 24-month dose-finding study had been completed, and 30 patients had been enrolled in an

72 Enrolment has been completed, and follow-up is ongoing.

73 A systematic review of the literature was completed, and the Grading of Recommendations Assess

74 2719 follow-up visits were completed, and 99 pregnancies were observed in 89 w

75 Transit through megakaryocytes can be completed as rapidly as minutes, after which neutroph

76 This study was completed as part of the National Heart, Lung, and B

77 The work was completed as part of the PhysioNet 2019 Challenge al

78 Hippocampus-dependent cognitive tasks were completed as well.

79 s extract these lipids after their synthesis is completed at the inner membrane and transport them to

80 A self-harm questionnaire was completed at ages 16 years and 21 years.

81 ay (MID) task during functional neuroimaging was completed at baseline and after 2 weeks of treatment

82 d P-wave duration and atrial late potentials were completed at 0, 10, and 24 months.

83 Follow-up assessments were completed at 3 months post-injury.

84 Statistical comparisons were completed at 6, 8, and 12 months of age.

85 Neuromuscular assessments were completed at baseline and for 45 min post-exercise.

86 Weight measurements were completed at baseline, and then weekly for 4 weeks,

87 Organizational assessments were completed at sites once before and 4 times after im

88 ll necessary procedures and optimal settings are completed automatically by the software.

89 A 5-video test batch was completed before and after scoring of the four 5-vid

90 ADC maturation was completed between 1.3 and 2.4 years of age, dependin

91 ve observational studies of surgery patients were completed between 3/2017 and 12/2018.

92 The study is completed but survival follow-up is ongoing.

93 enhancer regions occurred before the switch was completed, but not after.

94 The core system is completed by additional functions that might be assum

95 The outer shell is completed by eight chloride atoms and twelve R(3) P g

96 tes a rearrangement, and the catalytic cycle is completed by reduction of the new enone.

97 It is completed by SNARE-mediated fusion of the autophagoso

98 tion and coupling of pairs of tyrosines, and is completed by TG proteolysis(3).

99 Further, the picture is completed by the observation that hAEC express A1, A2

100 ted by 1,548 (96.2%), and 24 weeks follow-up was completed by 1,503 (93.4%); follow-up was similar be

101 Twelve weeks follow-up was completed by 1,548 (96.2%), and 24 weeks follow-up w

102 n of 25 videos for the phase 2 module, which was completed by 121 new assessors from 5 countries.

103 he Moroccan Arabic version of the LARS score was completed by 143 patients.

104 ogy third decennial Professional Life Survey was completed by 2,313 cardiologists: 964 women (42%) an

105 The survey was completed by 2,961 patients (mean age 65.1 years, st

106 An online questionnaire was completed by 210 IBD patients in Canada.

107 The study was completed by 24 patients with schizophrenia spectrum

108 aire, along with other ICD-related measures, was completed by 2403 ICD recipients.

109 The study was completed by 30 HV, 27 FD-starters, and 18 FD-stoppe

110 ening group who were mailed a FIT, screening was completed by 33.1%.

111 The study was completed by 45 overweight men and postmenopausal wo

112 The patient survey was completed by 513 patients with mild (26%), moderate

113 efecation and Fecal Continence questionnaire was completed by a representative sample of the adult Du

114 Carba-R NxG testing was completed by Cepheid (Sunnyvale, CA), blinded to gen

115 Data extraction was completed by independent pairs of reviewers.

116 uation, and release criteria of the product, was completed by isolation facilities participating at t

117 , 2011, and November 14, 2014, and follow-up was completed by January 15, 2018.

118 rlands, and the United States, and follow-up was completed by May 2018.

119 The study was completed by the development of a highly efficient r

120 This was completed by the operational determination of the ir

121 19-100; 31 men] using the standard technique was completed by three thoracic radiologists to assess i

122 Quality appraisal was completed by two reviewers independently in duplicat

123 Baseline quality-of-life questionnaires were completed by 1438 (92%) of 1566 patients and 9-mont

124 Clinical utility surveys of MRI examinations were completed by 150 physicians.

125 ical interactions at 1203 private facilities were completed by 24 standardised patients (16 men, eigh

126 Six-month assessments were completed by 258 participants (129 intervention, 12

127 Cognitive performance assessments were completed by 5,972 and 4,939 respondents at 11 year

128 Quality-of-life questionnaires were completed by 595 (75%) of the 798 trial participant

129 Study visits were completed by 89%, 77%, and 75% of men at months 2,

130 In addition, questionnaires were completed by children, parents and dentists.

131 All assessments were completed by independent evaluators masked to treat

132 DOT or VOT observation records were completed by observers until treatment or study end

133 nd posttreatment examinations and treatments were completed by ophthalmologists with expertise in ROP

134 ymised data from PARCA-R questionnaires that were completed by parents of 2-year-old children in thre

135 Subgroup analyses were completed by SCH genotype.

136 een November 2013 and July 2017; assessments were completed by the end of February 2018.

137 Data extraction and risk of bias assessment were completed by the same two reviewers.

138 Follow-up was completed December 2017.

139 the time at which half of the daily activity is completed) did not vary across level of VF damage.

140 FACT-P and EQ-5D-5L were completed during cycles 1-7, then every other cycle

141 ,5S)-4,8-dihydroxy-3,4-dihydrovernoniyne has been completed employing the asymmetric dihydroxylation

142 emical desulfinylation of an open fullerene, was completed, even though it is inhibited by the endohe

143 Twenty-four-hour urine collections were completed every 4 wk to determine study compliance

144 After osseous recontouring was completed, flaps were sutured and compressed, and bo

145 On Days 1 and 10, a sleep study was completed following exposure to MIH or the SP.

146 syn), a range of recognition studies can now be completed for producing novel supramolecular catalyst

147 Phase 3 trials have also been completed for bempedoic acid (targeting ATP-citrate

148 Treadmill test was completed for 128/212 (60%) patients.

149 Postoperative imaging was completed for 19 patients >1 year after surgery and

150 Follow-up at 180 days was completed for 779 patients (99.7%).

151 llow-up of 10 years until December 31, 2015, was completed for all participants.

152 Follow-up at 24 months was completed for more than 90% of the participants.

153 hesis were obtained when statistical testing was completed for that hypothesis; this occurred at the

154 Imaging studies were completed for 40 patients (mean age, 40.4 years; 23

155 BPI and BFI were completed for 7 consecutive days (days -6 to 1 incl

156 Prenatal ultrasounds were completed for each twin, and histomorphologic analy

157 Separate analyses were completed for SP and LP, using 2-by-2 contingency t

158 ata from 3 studies in the United States that were completed from 2012 to 2013, 2006 to 2008, and 1959

159 amidine and (+)-14,15-dehydrostrempeliopine, were completed from a late-stage divergent intermediate.

160 These operations are completed in just one single step, thanks to the phy

161 tocol with ease, and the entire pipeline can be completed in <5 d.

162 The entire procedure can be completed in 10 d.

163 bust, reliable and reproducible protocol can be completed in 2-3 d and can be paused at several stage

164 Preparation of single-cell suspensions can be completed in 2.5 h.

165 The presented protocol can be completed in 4 d and quantifies metabolic fluxes with

166 The protocol described herein can be completed in 4 d.

167 The smFISH procedure described here can be completed in 4-5 d.

168 ines have been established, the protocol can be completed in 5 d, with a throughput of hundreds to th

169 n of SWNTs to expression quantification, can be completed in 5 d.

170 sample preparation to HCP identification) to be completed in 7-8 h while demonstrating the ability to

171 The method can be completed in a few hours without the need for next-ge

172 s small enough such that the simulations can be completed in a short time frame but large enough to e

173 The same chiral analysis can now be completed in almost a third of the time with the addi

174 limit of detection of a single copy and can be completed in around 15 min.

175 Overall, the analysis of ZIKV RNA can be completed in less than 1 h, including amplification a

176 Sequencing using the nanopore platform could be completed in less than an hour, and samples could be

177 0%) of Tregs, reinforcing that MSRE-qPCR can be completed in less time than other methods with the sa

178 er sample sizes and replicate numbers should be completed in order to ascertain any changes in aroma

179 ble more, larger trials in kidney disease to be completed in the current era of burdensome regulation

180 ventional protocol, expansion pathology, can be completed in ~1 d with immunostained tissue sections

181 Ctx-IF can be completed in ~1 week and provides an opportunity to s

182 The whole protocol can be completed in ~7 d, including ~5 d required for the de

183 Similarly, fewer clinical trials have been completed in PDAC (n = 608) compared with breast (n

184 eurons with adeno-associated viruses (AAVs), is completed in a few minutes and allows stable transgen

185 The protecting-group-free synthesis is completed in four steps and 41% overall yield.

186 Haem synthesis is completed in mitochondria, with ferrochelatase adding

187 ls, demonstrating that reverse transcription is completed in the nucleus.

188 ing nuclear import, revealing that uncoating is completed in the nucleus.

189 Bq), labeling of (18)F-rhPSMA-5 to -10 by IE was completed in < 20 min (radiochemical yields, 58% +/-

190 Twelve-month follow-up was completed in 148 of 152 randomized subjects (97.3%).

191 Cycloplegic refraction was completed in 15 051 children 6 to 72 months of age.

192 Angiographic follow-up at 25 months was completed in 167 patients (91.8%), and the median cl

193 Serum CrAg testing was completed in 227 patients with cryptococcosis.

194 Pharmacotyping rapidly-expanded PDOs was completed in a median of 48 (range 18-102) days.

195 e clinical guidelines, this technical review was completed in accordance with the Grading of Recommen

196 Literature search was completed in August 2018.

197 from July 2017 to March 2019, and follow-up was completed in August 2019.

198 Follow-up was completed in December 2017.

199 ollment began in December 2007 and follow-up was completed in February 2019.

200 The final follow-up visit was completed in January 2020.

201 een January 2016 and January 2019; follow-up was completed in June 2019.

202 Analysis was completed in line with the process set out within co

203 A literature search was completed in PubMed, PsycINFO, and Scopus.

204 solution computed tomographic (HRCT) imaging were completed in a subset of participants at age 26.

205 cokinetic and anti-drug antibody assessments were completed in participants with at least 56 days of

206 For both cohorts combined, 389 HBsAg tests were completed in the alert group compared to 177 HBsAg

207 Critical appraisal was completed independently by 2 investigators.

208 In other words, the drug-disease matrix to be completed is low-rank.

209 eparation of daughter cells once mitosis has been completed, is executed in fungal and animal cells b

210 Once the form was completed it was collected by EGPAF staff and entere

211 and September 14, 2017; long-term follow-up was completed July 30, 2018.

212 Follow-up was completed June 24, 2019.

213 le research into non-miRNA sRNA function has been completed, likely due to some major barriers that p

214 A retrospective analysis was completed of recipients of a living donor liver tran

215 Vast amount of research has been completed on the aroma profile of celery.

216 Optimisation was completed on 15 isolates of Escherichia coli, showin

217 Thermal imaging at 8-um to 13-um wavelengths was completed on 30 test subjects with a suspected activ

218 Trial enrolment began on March 30, 2012, and was completed on April 10, 2014.

219 Patient follow-up to 3 months was completed on April 12, 2018.

220 Follow-up was completed on January 26, 2019.

221 Final follow-up was completed on July 21, 2020.

222 The final 6-month outcome assessment was completed on June 9, 2017.

223 and Sept 18, 2017, and the follow-up period was completed on March 1, 2018.

224 up for 1 year (follow-up of all participants was completed on March 7, 2018).

225 ventional testing began on Nov 14, 2016, and was completed on Nov 26, 2017, for tests done between Ma

226 Final 28-day follow-up visit was completed on November 28, 2018.

227 15, 2018, through March 27, 2019; follow-up was completed on November 4, 2019.

228 commenced on October 25, 2016, and follow-up was completed on October 22, 2018.

229 g a variety of NK cell activation conditions was completed on primary human NK cells and the NK92MI c

230 RAI assessments were completed on 36,261 unique patients presenting to s

231 Nutritional Status and Growth (STRONGkids)] were completed on admission.

232 SP and LP UATs were completed on all included patients.

233 Confusion Assessment Method and Sour Seven) were completed once daily.

234 Outcome measures were completed online by participants or a paper questio

235 its prolonged maturation time course, which is completed only by end of adolescence.

236 A number of placebo-controlled studies have been completed or are underway utilizing IL-1, IL-23, IL

237 T-cell epitopes targeted in type 1 diabetes was completed over a decade ago, providing an important

238 k-free functional magnetic resonance imaging was completed prior to randomization and 1 month followi

239 romotes cell cycle progression before repair is completed resulting in mitotic catastrophe.

240 Thirty-nine biopsies were completed, resulting in 12/39 (30.8%) malignancies

241 Our data show that after ER fusion is completed, RHD3 is degraded by LNPs so that nascent t

242 All non-N-back tasks were completed several days separate from the N-back by

243 es on Science With Treatment Recommendations were completed since 2015 are also summarized here.

244 dverse events included 16 deaths, 4 of which were completed suicides (GSP=2; GHE=2), and 12 of which

245 f the Grand Ethiopian Renaissance Dam (GERD) is completed, the Nile will have two of the world's larg

246 While more research needs to be completed, this study will help update cancer screeni

247 No systematic study has been completed to determine the effects of molecular cro

248 ew of 73 horizontal ridge augmentation cases was completed to assess the clinical outcomes, 53 of tho

249 Furthermore, a matched pair analysis was completed to determine structural changes that impac

250 profiling of 67 critically injured patients was completed to establish a metabolic signature associa

251 Statistical analysis was completed to identify whether the use of postoperati

252 TWAS (transcriptome-wide association study) was completed to integrate transcriptomic data from 233

253 ometry and targeted gene expression analyses were completed to assess pericyte quantity and function

254 groups, and cognitive debriefing interviews were completed to define content.

255 Two studies were completed to determine clinical performance.

256 Systematic reviews were completed to examine the relation among maternal di

257 first synthesis of lacto-N-hexaose (LNH) has been completed using a convergent strategy.

258 t total synthesis of halistatins 1 and 2 has been completed using Cr-mediated coupling reactions for

259 of hepatology providers in the United States was completed using primary and secondary data sources.

260 opsies of (18)F-fluciclovine-defined targets were completed using a 3-dimensional visualization and n

261 ung tissue from a representative mouse model were completed using quantitative PCR.

262 Methylation assays were completed using the Infinium HumanMethylation450 Be

263 Gene expression measurements were completed using transcriptome-wide RNA sequencing.

264 tions relate to when diagnostic tests should be completed, which diagnostic tests to utilize, and the

265 ducing Streptomyces clavuligerus ATCC 27 064 is completed, which contains 7163 newly annotated genes.

266 The SSDT was completed while looking at a photograph of one's own

267 This study was completed with 49 women.

268 Retinal segmentation was completed with DOCTRAP software, creating average vo

269 d group overall, 66.2% of the order sessions were completed with 1 record open, including 34.5% of ED

270 Data search and extraction were completed with a standardised data form and any dis

271 protocol comprises three phases that can all be completed within 1 d.

272 proteins of interest by western blotting can be completed within 1-2 weeks.

273 The overall analysis could be completed within 15 min.

274 whole protocol, including the analysis, can be completed within 2 weeks.

275 It can be completed within 24 weeks (using Step 5A/C) or 10 wee

276 rains have been generated, this protocol can be completed within 30 min to a few hours, depending on

277 on of microscopy data and image analysis can be completed within 5 d, requiring only standard laborat

278 matographic strip test for LMG detection can be completed within 5 min without any incubation, washin

279 Akron-seq can be completed within 6 d, and sequencing and analysis can

280 within 6 d, and sequencing and analysis can be completed within 6 d.

281 The overall operation can be completed within 7 min of sample loading.

282 The procedure described in this protocol can be completed within 8 d.

283 Computational tasks can be completed within a few hours, followed by 1-2 weeks o

284 The entire procedure can be completed within a few weeks.

285 This task can be completed within a single session, allowing for studi

286 nalysis) for both 3D and 4D-LC/MS setups can be completed within less than 1-2 days, compared to week

287 origins are indispensable for replication to be completed within S-phase period.

288 trigger a developmental pathway that cannot be completed within the growing season, referred to as a

289 ng 3D T2 mapping technique at 3.0 T that can be completed within the period of adenosine stress (<=4

290 The protocol can be completed within ~9 d for four biological replicates

291 The detection is completed within 25-30 min after amplification.

292 rall the entire workflow of data acquisition is completed within a day using the multidimensional on-

293 The process is completed within seconds, holding great potential for

294 Ultrasonic debridement was completed within 24 hours in FMD and FMUD groups.

295 lytes extraction from 100 mL aqueous samples was completed within 50 min and stripping in methanol re

296 lts suggest that this macroevolutionary jump was completed within a relatively short time interval (9

297 h a viscosity of ca. 21.6 cP at 40 degrees C was completed within the fluorescence lifetime, so that

298 asurement Information System (PROMIS) scales were completed within 1 month poststroke and again at 6

299 FibroScan examinations with M or XL probe were completed within the 2 weeks of the biopsy analysis

300 ral proteins and the viral life cycle cannot be completed without protease activity.